Bordetella bronchiseptica pneumonia in a patient with lung cancer; a case report of a rare infection

by Manlio Monti, Danila Diano, Francesco Allegrini, Angelo Delmonte, Valentina Fausti, Paola Cravero, Giulia Marcantognini, Giovanni Luca Frassineti
Published 2017-09-01

Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer

by Paola Ulivi, Matteo Canale, Alessandro Passardi, Giorgia Marisi, Martina Valgiusti, Giovanni Luca Frassineti, Daniele Calistri, Dino Amadori, Emanuela Scarpi
Published 2018-01-01

Case Report: Stevens-Johnson Syndrome and Hepatotoxicity Induced by Osimertinib Sequential to Pembrolizumab in a Patient With EGFR-Mutated Lung Adenocarcinoma

by Caterina Gianni, Giuseppe Bronte, Angelo Delmonte, Marco Angelo Burgio, Kalliopi Andrikou, Manlio Monti, Cecilia Menna, Giovanni Luca Frassineti, Lucio Crinò
Published 2021-08-01

Equivalent Efficacy but Different Safety Profiles of Gemcitabine Plus Nab-Paclitaxel and FOLFIRINOX in Metastatic Pancreatic Cancer

by Ilario Giovanni Rapposelli, Andrea Casadei-Gardini, Caterina Vivaldi, Giulia Bartolini, Laura Bernardini, Alessandro Passardi, Giovanni Luca Frassineti, Valentina Massa, Alessandro Cucchetti
Published 2021-05-01

Performance indicators for monitoring the integrated care pathway of patients with colorectal cancer: the E.Pic.A. project

by Andrea Ricotti, Giovanni Messori Ioli, Mattia Altini, Letizia Bachini, William Balzi, Giovanni Luca Frassineti, Fabrizio Gemmi, Ilaria Massa, Andrea Pierini, Oscar Bertetto, Patrizia Racca
Published 2019-06-01

Melanoma metastasis mimicking gastric cancer: a challenge that starts from diagnosis

by Manlio Monti, Massimo Guidoboni, Devil Oboldi, Giulia Bartolini, Federica Pieri, Silvia Ruscelli, Alessandro Passardi, Laura Ridolfi, Francesco De Rosa, Francesco Giulio Sullo, Giovanni Luca Frassineti
Published 2021-02-01

Circulating VEGF and eNOS variations as predictors of outcome in metastatic colorectal cancer patients receiving bevacizumab

by Giorgia Marisi, Emanuela Scarpi, Alessandro Passardi, Oriana Nanni, Angela Ragazzini, Martina Valgiusti, Andrea Casadei Gardini, Luca Maria Neri, Giovanni Luca Frassineti, Dino Amadori, Paola Ulivi
Published 2017-05-01

Impact of Pre-Treatment Lactate Dehydrogenase Levels on Prognosis and Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer.

by Alessandro Passardi, Emanuela Scarpi, Stefano Tamberi, Luigi Cavanna, Davide Tassinari, Annalisa Fontana, Sara Pini, Ilaria Bernardini, Caterina Accettura, Paola Ulivi, Giovanni Luca Frassineti, Dino Amadori
Published 2015-01-01

Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study

by Leonardo Solaini, Fabrizio D’Acapito, Alessandro Passardi, Massimo Framarini, Francesca Tauceri, Daniela Di Pietrantonio, Giovanni Luca Frassineti, Andrea Casadei Gardini, Alessandro Cucchetti, Davide Cavaliere, Giorgio Ercolani
Published 2019-03-01

Prognostic role of a new index (multi inflammatory index) in patients with metastatic colorectal cancer: results from the randomized ITACa trial

by Andrea Casadei Gardini, Emanuela Scarpi, Martina Valgiusti, Manlio Monti, Silvia Ruscelli, Laura Matteucci, Giulia Bartolini, Bernadette Vertogen, Flavia Pagan, Giulia Rovesti, Giovanni Luca Frassineti, Alessandro Passardi
Published 2020-09-01

KRAS, BRAF and PIK3CA status in squamous cell anal carcinoma (SCAC).

by Andrea Casadei Gardini, Laura Capelli, Paola Ulivi, Massimo Giannini, Eva Freier, Stefano Tamberi, Emanuela Scarpi, Alassandro Passardi, Wainer Zoli, Angela Ragazzini, Dino Amadori, Giovanni Luca Frassineti
Published 2014-01-01

Heterogeneity of Response and Immune System Activity during Treatment with Nivolumab in Hepatocellular Carcinoma: Results from a Single-Institution Retrospective Analysis

by Ilario Giovanni Rapposelli, Serena De Matteis, Paola Lanuti, Martina Valgiusti, Giulia Bartolini, Paola Ulivi, Giorgia Marisi, Federica Pedica, Valentina Burgio, Giovanni Luca Frassineti, Stefano Cascinu, Andrea Casadei-Gardini
Published 2021-01-01

Right- vs. Left-Sided Metastatic Colorectal Cancer: Differences in Tumor Biology and Bevacizumab Efficacy

by Paola Ulivi, Emanuela Scarpi, Elisa Chiadini, Giorgia Marisi, Martina Valgiusti, Laura Capelli, Andrea Casadei Gardini, Manlio Monti, Silvia Ruscelli, Giovanni Luca Frassineti, Daniele Calistri, Dino Amadori, Alessandro Passardi
Published 2017-06-01

Effectiveness of bevacizumab in first- and second-line treatment for metastatic colorectal cancer: ITACa randomized trial

by Elisabetta Petracci, Emanuela Scarpi, Alessandro Passardi, Annibale Biggeri, Carlo Milandri, Stefano Vecchia, Fabio Gelsomino, Davide Tassinari, Stefano Tamberi, Ilaria Bernardini, Caterina Accettura, Giovanni Luca Frassineti, Dino Amadori, Oriana Nanni
Published 2020-07-01

¹H-NMR Based Serum Metabolomics Highlights Different Specific Biomarkers between Early and Advanced Hepatocellular Carcinoma Stages

by Andrea Casadei-Gardini, Laura Del Coco, Giorgia Marisi, Fabio Conti, Giulia Rovesti, Paola Ulivi, Matteo Canale, Giovanni Luca Frassineti, Francesco Giuseppe Foschi, Serena Longo, Francesco Paolo Fanizzi, Anna Maria Giudetti
Published 2020-01-01

Chemotherapy and palliative care near end-of life: examining the appropriateness at a cancer institute for colorectal cancer patients

by Ilaria Massa, Oriana Nanni, Flavia Foca, Marco Maltoni, Stefania Derni, Nicola Gentili, Giovanni Luca Frassineti, Andrea Casadei Gardini, Martina Valgiusti, Dino Amadori, Elena Prati, Mattia Altini, Davide Gallegati, Elisabetta Sansoni
Published 2018-06-01

Erratum: Passardi, A. et al. Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study. <i>Cancers</i> 2019, <i>11</i...

by Alessandro Passardi, Emanuela Scarpi, Elisa Neri, Elisabetta Parisi, Giulia Ghigi, Giorgio Ercolani, Andrea Gardini, Giuliano La Barba, Flavia Pagan, Andrea Casadei-Gardini, Martina Valgiusti, Fabio Ferroni, Giovanni Luca Frassineti, Antonino Romeo
Published 2020-01-01

Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study

by Alessandro Passardi, Emanuela Scarpi, Elisa Neri, Elisabetta Parisi, Giulia Ghigi, Giorgio Ercolani, Andrea Gardini, Giuliano La Barba, Flavia Pagan, Andrea Casadei-Gardini, Martina Valgiusti, Fabio Ferroni, Giovanni Luca Frassineti, Antonino Romeo
Published 2019-05-01

Neoadjuvant treatment (FOLFOX4 plus hypofractionated tomotherapy) for patients with locally advanced rectal cancer: a multicenter phase II trial

by Alessandro Passardi, Ilario Giovanni Rapposelli, Emanuela Scarpi, Elisa Neri, Elisabetta Parisi, Giulia Ghigi, Giorgio Ercolani, Andrea Avanzolini, Davide Cavaliere, Britt Rudnas, Martina Valgiusti, Domenico Barone, Fabio Ferroni, Giovanni Luca Frassineti, Antonino Romeo
Published 2020-12-01

Comprehensive analysis of DNA damage repair genes reveals pathogenic variants beyond BRCA and suggests the need for extensive genetic testing in pancreatic cancer

by Ilario Giovanni Rapposelli, Valentina Zampiga, Ilaria Cangini, Valentina Arcangeli, Mila Ravegnani, Martina Valgiusti, Sara Pini, Stefano Tamberi, Giulia Bartolini, Alessandro Passardi, Giovanni Martinelli, Daniele Calistri, Giovanni Luca Frassineti, Fabio Falcini, Rita Danesi
Published 2021-05-01